Sunday, July 13, 2014

Roche posts modest profit gain for 2012

March 16. 2013 11:41PM
Story Tools
PrintPrint | E-MailEMail | SaveSave | Hear Generate QR Code QR
Send to Kindle

(AP) Swiss drug maker Roche Holding AG has posted a 2.4 percent increase in its full-year profits as demand grew for its cancer medicines and diagnostic tests used by clinical laboratories.

The Basel-based company said Wednesday that it had a net profit last year of 9.773 billion Swiss francs ($10.57 billion) compared with 9.544 billion Swiss francs for 2011.

It credited the rise to the approval of the breast cancer medicine Perjeta and the weakening of the Swiss franc against the dollar and Japanese yen.

The world's biggest manufacturer of cancer drugs, which reports earnings only every six months, has in recent years battled against the strength of the Swiss franc.

Roche CEO Severin Schwan said 2012 was a very good year for Roche with strong sales of well-known drugs.

Associated Press

comments powered by Disqus Commenting Guidelines
Mortgage Minute

Search for New & Used Cars

Used New All

Search Times Leader Classifieds to find just the home you want!

Search Times Leader Classifieds to find just what you need!

Search Pet Classifieds
Dogs Cats Other Animals

Social Media/RSS
Times Leader on Twitter
Times Leader on Youtube
Times Leader on Google+
The Times Leader on Tumblr
The Times Leader on Pinterest
Times Leader RSS Feeds